FI48922C - Menetelmä farmaseuttisesti vaikuttavien uusien, sekä raseemisten että optisesti aktiivisten substituoitujen 1-fenoksi-2-hydroksi-3-tert.buty yliaminopropaanien ja niiden suolojen valmistamiseksi. - Google Patents

Menetelmä farmaseuttisesti vaikuttavien uusien, sekä raseemisten että optisesti aktiivisten substituoitujen 1-fenoksi-2-hydroksi-3-tert.buty yliaminopropaanien ja niiden suolojen valmistamiseksi.

Info

Publication number
FI48922C
FI48922C FI681664A FI166468A FI48922C FI 48922 C FI48922 C FI 48922C FI 681664 A FI681664 A FI 681664A FI 166468 A FI166468 A FI 166468A FI 48922 C FI48922 C FI 48922C
Authority
FI
Finland
Prior art keywords
aminopropanes
racemic
phenoxy
tert
hydroxy
Prior art date
Application number
FI681664A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI48922B (xx
Inventor
Herbert Koeppe
Karl Zeile
Albrecht Engelhardt
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of FI48922B publication Critical patent/FI48922B/fi
Application granted granted Critical
Publication of FI48922C publication Critical patent/FI48922C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI681664A 1967-06-15 1968-06-14 Menetelmä farmaseuttisesti vaikuttavien uusien, sekä raseemisten että optisesti aktiivisten substituoitujen 1-fenoksi-2-hydroksi-3-tert.buty yliaminopropaanien ja niiden suolojen valmistamiseksi. FI48922C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1967B0093025 DE1593782B2 (de) 1967-06-15 1967-06-15 1-nitrilophenoxy- 2- hydroxy -3- tert.butylaminopropane, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Publications (2)

Publication Number Publication Date
FI48922B FI48922B (xx) 1974-10-31
FI48922C true FI48922C (fi) 1975-02-10

Family

ID=6986720

Family Applications (1)

Application Number Title Priority Date Filing Date
FI681664A FI48922C (fi) 1967-06-15 1968-06-14 Menetelmä farmaseuttisesti vaikuttavien uusien, sekä raseemisten että optisesti aktiivisten substituoitujen 1-fenoksi-2-hydroksi-3-tert.buty yliaminopropaanien ja niiden suolojen valmistamiseksi.

Country Status (17)

Country Link
JP (2) JPS51100B1 (xx)
AT (8) AT289077B (xx)
BE (1) BE716647A (xx)
BG (6) BG15039A3 (xx)
CH (1) CH495950A (xx)
DE (1) DE1593782B2 (xx)
DK (1) DK127059B (xx)
ES (6) ES354823A1 (xx)
FI (1) FI48922C (xx)
FR (2) FR1583559A (xx)
GB (1) GB1187546A (xx)
IE (1) IE32373B1 (xx)
IL (1) IL30181A (xx)
MY (1) MY7300288A (xx)
NL (2) NL6808196A (xx)
SE (1) SE355571B (xx)
YU (7) YU33780B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3937834A (en) 1970-10-02 1976-02-10 Ciba-Geigy Corporation Pharmaceutical preparations
JPS57125772U (xx) * 1981-01-30 1982-08-05
DE3744371A1 (de) * 1987-12-29 1989-07-13 Jacobs Suchard Ag Verpackung fuer suesswaren
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL301580A (xx) * 1962-12-11

Also Published As

Publication number Publication date
FI48922B (xx) 1974-10-31
IL30181A0 (en) 1968-08-22
ES368396A1 (es) 1971-05-01
ES368398A1 (es) 1971-05-01
JPS5112613B1 (xx) 1976-04-21
AT289079B (de) 1971-04-13
IE32373L (en) 1968-12-15
AT289082B (de) 1971-04-13
ES368395A1 (es) 1971-05-01
BG15038A3 (bg) 1975-06-10
NL136601C (xx)
YU33778B (en) 1978-05-15
YU33779B (en) 1978-05-15
DE1593782A1 (de) 1972-04-20
DE1593782B2 (de) 1976-09-09
YU229074A (en) 1977-10-31
MY7300288A (en) 1973-12-31
YU33775B (en) 1978-05-15
NL6808196A (xx) 1968-12-16
IE32373B1 (en) 1973-07-11
IL30181A (en) 1972-01-27
JPS51100B1 (xx) 1976-01-05
YU35578B (en) 1981-04-30
BG15039A3 (bg) 1975-12-15
YU33780B (en) 1978-05-15
AT289081B (de) 1971-04-13
AT289076B (de) 1971-04-13
BG15037A3 (bg) 1975-12-12
BG15041A3 (bg) 1975-10-22
SE355571B (xx) 1973-04-30
BG15040A3 (bg) 1975-10-25
BE716647A (xx) 1968-12-16
FR8162M (xx) 1970-08-24
YU228974A (en) 1977-10-31
YU228874A (en) 1977-10-31
CH495950A (de) 1970-09-15
YU33776B (en) 1978-05-15
FR1583559A (xx) 1969-11-14
AT289077B (de) 1971-04-13
YU33777B (en) 1978-05-15
YU229474A (en) 1977-10-31
ES368399A1 (es) 1971-05-01
AT289080B (de) 1971-04-13
GB1187546A (en) 1970-04-08
YU229374A (en) 1980-09-25
BG15042A3 (bg) 1975-10-20
ES354823A1 (es) 1970-02-16
AT289067B (de) 1971-04-13
YU229174A (en) 1977-10-31
YU229274A (en) 1977-10-31
DK127059B (da) 1973-09-17
ES368401A1 (es) 1971-05-01
AT289078B (de) 1971-04-13

Similar Documents

Publication Publication Date Title
FI48460C (fi) Menetelmä farmakologisesti vaikuttavien uusien amino-dihalogeenifenyyl ietyyliamiinien valmistamiseksi.
FI49300C (fi) Menetelmä terapeuttisesti aktiivisten 1,4-dihydropyridiinijohdannaiste n valmistamiseksi.
DK131029B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-alkylaminopropaner eller syreadditionssalte deraf.
DK129447B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-sek.-alkylaminopropaner eller syreadditionssalte heraf.
FI48189C (fi) Menetelmä uusien raseemisten tai optisesti aktiivisten, terapeuttisest i aktiivisten norskopolamiinijohdannaisten valmistamiseksi
ES393914A0 (es) Procedimiento de preparacion de nuevos derivados de acido fenilacetico, racemicos, u opticamente activos
FI50969C (fi) Menetelmä uusien, sydämen toimintaan ja verenkiertoon vaikuttavien, tr isyklisesti substituoitujen 1-naftoksi-2-hydroksi-3-etyyliamino-propaa nien ja niiden suolojen valmistamiseksi.
FI50876C (fi) Menetelmä terapeuttisesti vaikuttavien N-substituoitujen imidatsolien ja niiden suolojen valmistamiseksi.
FI45968C (fi) Analogiamenetelmiä raseemisten tai optisesti aktiivisten, farmakodynaa misesti tehokkaiden 5-fenyyli-6,7-bentsomorfaanien valmistamiseksi.
DK124081B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive piperazinderivater eller syreadditionssalte deraf.
FI51704C (fi) Menetelmä terapeuttisesti aktiivisten 4-metoksi-5,12-diokso-6,9,11-tri hydroksi-7-(0-2,3,6-tridesoksi-3-amino-1-L-lyksoheksosyyli)-7-asetyyli heksahydronaftaseenijohdannaisten ja näiden suolojen valmistamiseksi.
FI49512C (fi) Menetelmä uusien terapeuttisesti aktiivisten s-triatsinyylipiperatsiin ijohdannaisten valmistamiseksi.
FI47365C (fi) Menetelmä valmistaa uusia terapeuttisesti vaikuttavia indolijohdannais ia.
DK119877B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme carboxylsyrer eller farmaceutisk acceptable salte heraf.
DK120597B (da) Analogifremgangsmåde til frematilling af racemiske eller optisk aktive 10b-substituerede hexahydro-eller octahydrophenanthridinderivater eller salte deraf.
FI48922C (fi) Menetelmä farmaseuttisesti vaikuttavien uusien, sekä raseemisten että optisesti aktiivisten substituoitujen 1-fenoksi-2-hydroksi-3-tert.buty yliaminopropaanien ja niiden suolojen valmistamiseksi.
DK119009B (da) Analogifremgangsmåde til fremstilling af optisk aktive eller racemiske 5,9-diethyl-2'-hydroxy-2-substituerede-6,7-benzomorphan-forbindelser eller syreadditionssalte deraf.
DK129235B (da) Fremgangsmåde til fremstilling af racemiske eller optisk aktive quinolinderivater eller syreadditionssalte deraf.
FI52861C (fi) Menetelmä antimikrobisesti vaikuttavien 2-(5-nitro-2-imidatsolyyli)-be ntsimidatsolien valmistamiseksi.
DK138988B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive morphinanderivater.
FI51182C (fi) Menetelmä uusien verensokeria alentavien 2-bentseenisulfonamidopyrimid iinijohdannaisten valmistamiseksi.
DK123102B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive benzo[b]thiopheneddikesyreforbindelser eller carboxylatsalte deraf.
FI48576C (fi) Menetelmä terapeuttisesti aktiivisten alfa-fluori-malonihappojohdannai sten valmistamiseksi.
DK121513B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive N-substituerede noratropiniumsalte.
FI45045C (fi) Menetelmä uusien terapeuttisesti vaikuttavien 5-nitro-2-furyyli-isoksa tsolijohdannaisten valmistamiseksi.